BridgeMD
New treatment option for Prehospital Emergency Medical Services
Official title The Pre-POCT-Non-Conveyance Trial: Prehospital Point-of-Care Testing to Support Non-Conveyance Decisions
ClinicalTrials.gov ID: NCT07503470
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether rapid blood tests performed in the ambulance can be implemented in routine prehospital assessment of adults who are initially considered for transport to hospital. Ambulance clinicians frequently assess adults who are transported to hospital but discharged shortly after arrival without requiring advanced diagnostic testing or treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged ≥18 years
- Emergency call or general practitioner-commissioned ambulance dispatch following telephone triage only, including video streaming triage, resulting...
- Initial on-scene assessments performed by the ambulance crew
- Patients initially considered for hospital conveyance based on clinical assessment
- Following telemedical consultation with an Emergency Medical Dispatch Centre (EMDC) physician, deemed eligible for point-of-care blood testing (POCT)
You likely can't join if
- Non-emergency calls (e.g., interfacility transport or scheduled patient transport)
- General practitioner-commissioned ambulance dispatches where the patient has been physically assessed by a general practitioner or another physician...
- Immediate need for emergency transport to hospital as determined by clinical assessment
- Persistent unstable vital signs outside predefined operational thresholds, except for known chronic baseline deviations (e.g., reduced oxygen...
- Inability to obtain venous or capillary blood samples
- Prior participation in the study within 30 days (to ensure complete outcome follow-up)
See the full eligibility criteria
- Adults aged ≥18 years
- Emergency call or general practitioner-commissioned ambulance dispatch following telephone triage only, including video streaming triage, resulting in ambulance dispatch
- Initial on-scene assessments performed by the ambulance crew
- Patients initially considered for hospital conveyance based on clinical assessment
- Following telemedical consultation with an Emergency Medical Dispatch Centre (EMDC) physician, deemed eligible for point-of-care blood testing (POCT)
- Hemodynamically and clinically stable according to predefined operational stability criteria (including Glasgow Coma Scale, blood pressure, oxygen saturation, and heart rate), with final eligibility determined by the...
- Non-emergency calls (e.g., interfacility transport or scheduled patient transport)
- General practitioner-commissioned ambulance dispatches where the patient has been physically assessed by a general practitioner or another physician before ambulance arrival
- Immediate need for emergency transport to hospital as determined by clinical assessment
- Persistent unstable vital signs outside predefined operational thresholds, except for known chronic baseline deviations (e.g., reduced oxygen saturation in patients with chronic obstructive pulmonary disease or chronic...
- Inability to obtain venous or capillary blood samples
- Prior participation in the study within 30 days (to ensure complete outcome follow-up)
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus N, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus N, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.